TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey.

Argnani L, Pellegrini C, Annibali O, Angelillo P, Amaducci E, Ballerini F, Bellisario F, Bernardelli A, Bruna R, Califano C, Cetani G, Daghia G, Derenzini E, Frolli A, Gaudio F, Guarente V, Gorgone A, Valentina LE, Lucchini E, Marino D, Nassi L, Nicoli P, Novo M, Palombi F, Patti C, Pavone V, Riva M, Russo F, Scapinello G, Severino A, Tani M, Vallisa D, Casadei B, Broccoli A, Zinzani PL

Open source

DOI: 10.1002/hon.70167
Published: 2026 Jan
Container: Hematological oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/hon.70167,
  title = {TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey.},
  author = {Argnani L and Pellegrini C and Annibali O and Angelillo P and Amaducci E and Ballerini F and Bellisario F and Bernardelli A and Bruna R and Califano C and Cetani G and Daghia G and Derenzini E and Frolli A and Gaudio F and Guarente V and Gorgone A and Valentina LE and Lucchini E and Marino D and Nassi L and Nicoli P and Novo M and Palombi F and Patti C and Pavone V and Riva M and Russo F and Scapinello G and Severino A and Tani M and Vallisa D and Casadei B and Broccoli A and Zinzani PL},
  year = {2026},
  journal = {Hematological oncology},
  doi = {10.1002/hon.70167},
  url = {https://doi.org/10.1002/hon.70167}
}

RIS

TY  - JOUR
TI  - TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey.
AU  - Argnani L
AU  - Pellegrini C
AU  - Annibali O
AU  - Angelillo P
AU  - Amaducci E
AU  - Ballerini F
AU  - Bellisario F
AU  - Bernardelli A
AU  - Bruna R
AU  - Califano C
AU  - Cetani G
AU  - Daghia G
AU  - Derenzini E
AU  - Frolli A
AU  - Gaudio F
AU  - Guarente V
AU  - Gorgone A
AU  - Valentina LE
AU  - Lucchini E
AU  - Marino D
AU  - Nassi L
AU  - Nicoli P
AU  - Novo M
AU  - Palombi F
AU  - Patti C
AU  - Pavone V
AU  - Riva M
AU  - Russo F
AU  - Scapinello G
AU  - Severino A
AU  - Tani M
AU  - Vallisa D
AU  - Casadei B
AU  - Broccoli A
AU  - Zinzani PL
PY  - 2026
JO  - Hematological oncology
DO  - 10.1002/hon.70167
UR  - https://doi.org/10.1002/hon.70167
ER  -

APA

L, A., C, P., O, A., P, A., E, A., F, B., F, B., A, B., R, B., C, C., G, C., G, D., E, D., A, F., F, G., V, G., A, G., LE, V., E, L., D, M., L, N., P, N., M, N., F, P., C, P., V, P., M, R., F, R., G, S., A, S., M, T., D, V., B, C., A, B., & PL, Z. (2026). TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey.. Hematological oncology. https://doi.org/10.1002/hon.70167

Source records

pubmed · retrieved 2026-09-26T03:32:40.320Z